Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Preservative Quantification Method Development – V 2.0

Posted on By

Analytical Method Development: SOP for Preservative Quantification Method Development – V 2.0

Standard Operating Procedure for Preservative Quantification Method Development in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/276/2025
Supersedes SOP/AMD/276/2022
Page No. Page 1 of 12
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

To outline a validated and standardized procedure for developing methods to quantify preservatives such as methylparaben, propylparaben, benzyl alcohol, and phenol in various pharmaceutical dosage forms using

HPLC or UV-visible spectrophotometry.

2. Scope

This SOP applies to the Analytical Method Development and Quality Control departments involved in developing, validating, and applying quantitative analytical methods for preservatives in parenterals, ophthalmics, oral liquids, and topical formulations.

3. Responsibilities

  • Analytical Scientist: Responsible for method development, validation, and documentation of results.
  • QC Analyst: Performs preservative assay in routine and stability testing using validated method.
  • QA Executive: Reviews method reports and ensures compliance with regulatory standards.
See also  Analytical Method Development: Flame Ionization Detection Method Setup - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring that the developed preservative quantification methods are validated and aligned with ICH and pharmacopeial standards.

5. Procedure

5.1 Target Preservatives

  • Methylparaben
  • Propylparaben
  • Benzyl Alcohol
  • Phenol

5.2 Method Development Strategy

  1. Select analytical technique based on preservative’s UV absorbance or retention behavior (e.g., HPLC with UV detection at 210–254 nm).
  2. Choose suitable mobile phase and buffer to resolve preservatives from matrix components.
  3. Optimize chromatographic parameters: flow rate, temperature, wavelength, column type.

5.3 Sample Preparation

  1. Weigh or measure appropriate quantity of formulation.
  2. Extract preservative in mobile phase or diluent; dilute to required volume.
  3. Filter through 0.45 µm membrane filter before injection.

5.4 Standard Preparation

  1. Prepare stock solutions of each preservative in mobile phase at 1000 µg/mL.
  2. Prepare working standards in the range of 20–200 µg/mL for calibration.

5.5 HPLC Conditions (Typical)

  • Column: C18, 250 mm × 4.6 mm, 5 µm
  • Mobile Phase: Water:Acetonitrile (65:35) with 0.1% phosphoric acid
  • Flow Rate: 1.0 mL/min
  • Detection Wavelength: 254 nm
  • Injection Volume: 20 µL
See also  Analytical Method Development: SOP for Dissolution Method for Delayed Release Tablets - V 2.0

5.6 Validation Parameters

  1. Specificity: Method should resolve all preservatives from excipients and matrix.
  2. Linearity: r² ≥ 0.999 across 80% to 120% of target concentration.
  3. Accuracy: Recovery between 98% and 102% at three concentration levels.
  4. Precision: % RSD ≤ 2.0% (intra-day and inter-day).
  5. Robustness: Confirm retention time and peak shape under varied conditions.

5.7 Acceptance Criteria

  • Content of each preservative should be within 90%–110% of label claim.
  • Peak purity index ≥ 0.999 using spectral overlay.
  • No co-eluting peaks with target preservatives.

6. Abbreviations

  • HPLC: High Performance Liquid Chromatography
  • UV: Ultraviolet
  • LOD: Limit of Detection
  • LOQ: Limit of Quantification
  • QA: Quality Assurance

7. Documents

  1. Preservative Quantification Log – Annexure-1
  2. Validation Chromatograms – Annexure-2
  3. Method Validation Report – Annexure-3

8. References

  • USP <561>, <1225>
  • ICH Q2(R1): Validation of Analytical Procedures
  • Ph. Eur. General Texts 5.1.3: Efficacy of Antimicrobial Preservation

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Deepak Mahajan Ritika Shah Sunita Reddy
Designation Method Development Scientist QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Preservative Quantification Log

Sample ID Preservative Label Claim (%) Found (%) RSD (%) Status
MDV-276-01 Methylparaben 0.18 0.179 1.2 Pass

Annexure-2: Validation Chromatograms

Overlay plots for methylparaben and propylparaben standards and samples across linearity range, with purity confirmation and retention time stability.

Annexure-3: Method Validation Report

The preservative quantification method was successfully validated in oral liquids and injectables. Parameters including accuracy, precision, linearity, specificity, and robustness were within acceptable limits. Method approved for routine and regulatory use.

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Expanded scope to include multiple dosage forms and preservative types Annual Review Sunita Reddy
02/03/2022 1.0 Initial SOP Release New SOP QA Head
See also  Analytical Method Development: Suitability Testing for Microbial Methods - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: The Importance of Visual Management in SOP Compliance Monitoring
Next Post: GMP Audit Concern: SOPs Lacking Cross-References Between QMS Modules

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version